Brief: Lilly To Acquire Point Biopharma

POINT Biopharma Global

03/10/2023 11:50

Oct 3 (Reuters) - Point Biopharma Global  PNT.O 
    * POINT BIOPHARMA GLOBAL: LILLY (NOT CO) WILL COMMENCE A TENDER OFFER TO
ACQUIRE
ALL OUTSTANDING SHARES OF POINT FOR A PURCHASE PRICE OF $12.50 PER SHARE IN CASH
    * LILLY TO ACQUIRE POINT BIOPHARMA TO EXPAND ONCOLOGY CAPABILITIES INTO
NEXT-GENERATION RADIOLIGAND THERAPIES
    * POINT BIOPHARMA GLOBAL INC: PROPOSED DEAL FOR $12.50 PER SHARE IN CASH
    * POINT BIOPHARMA GLOBAL INC: PROPOSED DEAL FOR AGGREGATE OF APPROXIMATELY
$1.4
BILLION
    * POINT BIOPHARMA GLOBAL INC: TRANSACTION HAS BEEN APPROVED BY BOARDS OF
DIRECTORS
OF BOTH COMPANIES

Further company coverage:  LLY.N   PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;;))